Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
Open Access
- 1 January 2006
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 119 (1) , 71.e9-71.e16
- https://doi.org/10.1016/j.amjmed.2005.02.033
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspectsHepatology, 2004
- Hepatitis B e Antigen and the Risk of Hepatocellular CarcinomaNew England Journal of Medicine, 2002
- Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis BHepatology, 2002
- Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis BNew England Journal of Medicine, 1996
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective studyHepatology, 1991
- The development of cirrhosis in patients with chronic type B hepatitis: A prospective studyHepatology, 1988
- NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERSThe Lancet, 1981
- Delayed HBsAg clearance in chronic hepatitis B viral infectionHepatology, 1981
- The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic CarriersThe Lancet Healthy Longevity, 1979